CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity - Wikidata - awgldk - TriplyDB

CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity

CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity

http://www.wikidata.org/entity/Q24567695

about

Role of berberine in Alzheimer's disease Isoproterenol-induced FKBP12.6/12 downregulation is modulated by ETA and ETB receptors and reversed by argirhein, a derivative of rhein Raisanberine protected pulmonary arterial rings and cardiac myocytes of rats against hypoxia injury by suppressing NADPH oxidase and calcium influx Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1.Role of endothelin receptor A and NADPH oxidase in vascular abnormalities.Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats.Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: role of autophagy.

P2860

Q28067321-9DB13A92-4E3E-4C9F-AA92-39A9ADA75F58 Q33565656-C23016D1-6357-437A-9634-267419F20399 Q33567412-D83F81D8-D1B2-4C35-A2CD-104A7929C6D1 Q34675044-0BA07E36-8F0F-4EB1-9318-8D8D57B0D499 Q36232841-F73B3D1A-CFCB-4320-9D08-05B51DBEE3D7 Q36405714-92B87A1F-1FE4-473A-9E90-90D14966D0DD Q37790995-31D6C219-F1C2-4B15-A0A0-48501252F7B3 Q41571658-0A6A4F6F-8C8F-4AC3-9275-BCA6DEA97D86 Q48194283-29B12DE4-65E6-4CE0-8F87-725AB160434F Q54321977-C5EDF8EA-C440-499B-B199-3BB771C94215

P2860

CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity

http://www.wikidata.org/entity/Q24567695

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

CPU86017, a berberine derivati ...... exerting antioxidant activity

@ast

CPU86017, a berberine derivati ...... exerting antioxidant activity

@en

CPU86017, a berberine derivati ...... exerting antioxidant activity

@nl

type

label

CPU86017, a berberine derivati ...... exerting antioxidant activity

@ast

CPU86017, a berberine derivati ...... exerting antioxidant activity

@en

CPU86017, a berberine derivati ...... exerting antioxidant activity

@nl

prefLabel

CPU86017, a berberine derivati ...... exerting antioxidant activity

@ast

CPU86017, a berberine derivati ...... exerting antioxidant activity

@en

CPU86017, a berberine derivati ...... exerting antioxidant activity

@nl

P1433

Q24567695-0BFBE441-8DC1-4C15-958B-7090598D1222

P1476

Q24567695-9A95AD40-7A19-4252-8C7C-AAC464CB00D0

P2093

Q24567695-06B35480-3AA8-42B0-A5D5-D15FE72B94D7

Q24567695-2226342F-49EF-4745-A059-A483390E6741

Q24567695-512F7989-9F8A-4009-9B53-E73B3DBE8666

Q24567695-A1EF7FA5-3FF2-461B-BC25-6A10A84D9114

Q24567695-B2E97E5B-4190-4368-8CE0-8CB2672B0BEA

Q24567695-D3A2EC64-BBE8-4A8C-9B7D-22C56144C572

P2860

Q24567695-0539E71E-D47F-4C9D-8ACC-AF274C280DC0

Q24567695-0A748B96-7AFB-4A1E-88BC-26FDAD98B6D7

Q24567695-1A702F7F-3340-46F5-85B7-730C775001A3

Q24567695-20C0CD2F-5583-4596-B586-D22EB9D3BC57

Q24567695-29FF1647-E92D-43BA-84D2-361EFF51D1D0

Q24567695-2A3F5D4E-3F1A-460C-A18A-86715AB5F310

Q24567695-38C8F336-C858-4B15-B2FF-C595A33BB850

Q24567695-42D68966-6F74-4843-824F-A0D6BB65852C

Q24567695-431EF062-4D9F-48FA-91F5-732A9D61E4BC

Q24567695-47C2AF9E-C455-44EE-95D1-CB119E88E087

P2888

Q24567695-99847E98-A9FA-4FED-9112-7987B627003F

P304

Q24567695-F48B8F99-9EE2-4DD8-A4F1-29DD1600FC94

P31

Q24567695-28B9F451-7735-4A1E-AFA6-DC64E15BFAE4

P3181

Q24567695-C31323C2-81DC-4CF0-9172-C07F3B6AE3E1

P356

Q24567695-232C4AD9-EE1B-476E-9320-84F11E1FBBF8

P407

Q24567695-89721658-E846-43B2-85ED-BEDB40E6ACEC

P433

Q24567695-C90A7A7B-DC38-4A1F-88C3-B205B62469F5

P478

Q24567695-79B32B3D-51DF-43E3-A849-FD0553E7229C

P577

Q24567695-4854F6CE-6CAD-4F33-966D-99D3E18A47D1

P5875

Q24567695-77ED6BF3-E53B-4C9E-ABF5-1FB6301491DA

P6179

Q24567695-74F82C57-CFE5-4C6E-9812-3B9C478BD357

P698

Q24567695-682ED5B9-4910-4EA5-B501-447D094DA293

P932

Q24567695-CDB45F44-6E6F-4770-970D-946993478F29

P3181

P356

P1433

Acta Pharmacologica Sinica

P1476

CPU86017, a berberine derivati ...... exerting antioxidant activity

@en

P2093

De-zai Dai

http://www.w3.org/2001/XMLSchema#string

Min-you Qi

http://www.w3.org/2001/XMLSchema#string

Na Li

http://www.w3.org/2001/XMLSchema#string

Yin Dai

http://www.w3.org/2001/XMLSchema#string

Yu Feng

http://www.w3.org/2001/XMLSchema#string

Yu-si Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping the balance right

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213

Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease.

Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.

Cardiac ryanodine receptor function and regulation in heart disease.

P2888

P304

165-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3167370

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/APS.2009.180

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41414407

http://www.w3.org/2001/XMLSchema#string

P6179

1032012209

http://www.w3.org/2001/XMLSchema#string

P698

20139899

http://www.w3.org/2001/XMLSchema#string

P932

4002834

http://www.w3.org/2001/XMLSchema#string